XML 11 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:    
Research and development $ 6,183,508 $ 11,235,861
General and administrative 3,210,357 5,567,416
Loss from operations (9,393,865) (16,803,277)
Other income (expense):    
Interest income 1,810,269 1,678,885
Interest expense (498,526) (491,287)
Total other income, net 1,311,743 1,187,598
Net loss $ (8,082,122) $ (15,615,679)
Net loss per share - basic $ (0.14) $ (0.27)
Net loss per share - diluted $ (0.14) $ (0.27)
Weighted average common shares outstanding - basic 59,414,489 58,791,603
Weighted average common shares outstanding - diluted 59,414,489 58,791,603